Recently, one study has assessed the prognostic value of the PD-L1 RNA expression in patients with NMIBC (with T1 tumours); however, a heterogeneous population in terms of adjuvant treatment regimen (BCG and mitomycin C) was analysed. The gene discussed is CD274; the disease is neoplasm.